These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21400564)

  • 1. Role of CD8 regulatory T-cells in multiple sclerosis.
    Kreft KL; Verbraak E; Wierenga-Wolf AF; Laman JD; Hintzen RQ
    Ann Neurol; 2011 Mar; 69(3):593; author reply 593-4. PubMed ID: 21400564
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis.
    Saxena A; Martin-Blondel G; Mars LT; Liblau RS
    FEBS Lett; 2011 Dec; 585(23):3758-63. PubMed ID: 21910991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ T cells in inflammatory demyelinating disease.
    Weiss HA; Millward JM; Owens T
    J Neuroimmunol; 2007 Nov; 191(1-2):79-85. PubMed ID: 17920696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
    Friese MA; Fugger L
    Brain; 2005 Aug; 128(Pt 8):1747-63. PubMed ID: 15975943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year study.
    Aristimuño C; de Andrés C; Bartolomé M; de las Heras V; Martínez-Ginés ML; Arroyo R; Fernández-Cruz E; Sánchez-Ramón S
    Clin Immunol; 2010 Feb; 134(2):148-57. PubMed ID: 19900844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis.
    Correale J; Villa A
    J Neuroimmunol; 2008 Mar; 195(1-2):121-34. PubMed ID: 18234356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of regulatory CD8+ T-lymphocytes and fall of activated CD8+ T-lymphocytes after i.v. methyl-prednisolone for multiple sclerosis relapse.
    Aristimuño C; Navarro J; de Andrés C; Martínez-Ginés L; Giménez-Roldán S; Fernández-Cruz E; Sánchez-Ramón S
    J Neuroimmunol; 2008 Nov; 204(1-2):131-5. PubMed ID: 18835045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
    Batoulis H; Addicks K; Kuerten S
    Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
    Johnson AJ; Suidan GL; McDole J; Pirko I
    Int Rev Neurobiol; 2007; 79():73-97. PubMed ID: 17531838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor-inducer T-cells in multiple sclerosis.
    Rose LM; Ledbetter JA; Ginsberg AH; Clark EA; Rothstein TL
    N Engl J Med; 1987 Jul; 317(2):118-9. PubMed ID: 2953974
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of CD8+ T cell repertoire in identical twins discordant and concordant for multiple sclerosis.
    Somma P; Ristori G; Battistini L; Cannoni S; Borsellino G; Diamantini A; Salvetti M; Sorrentino R; Fiorillo MT
    J Leukoc Biol; 2007 Mar; 81(3):696-710. PubMed ID: 17110420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects.
    Lysandropoulos AP; Jaquiéry E; Jilek S; Pantaleo G; Schluep M; Du Pasquier RA
    J Neuroimmunol; 2011 Apr; 233(1-2):240-4. PubMed ID: 21186064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of T-regulatory cells in multiple sclerosis].
    Rojas JI; González SJ; Patrucco L; Cristiano E
    Medicina (B Aires); 2010; 70(1):79-86. PubMed ID: 20228030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL; Wiendl H
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells.
    Ji Q; Goverman J
    Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavior of T lymphocytes, T helper and T suppressor, in multiple sclerosis. Preliminary report].
    Tilbery CP; Lima JG; Scheinberg MA; Santos LM; Yamada FT
    Rev Paul Med; 1984; 102(4):181-3. PubMed ID: 6240108
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood T-cell receptor beta chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution.
    Laplaud DA; Ruiz C; Wiertlewski S; Brouard S; Berthelot L; Guillet M; Melchior B; Degauque N; Edan G; Brachet P; Damier P; Soulillou JP
    Brain; 2004 May; 127(Pt 5):981-95. PubMed ID: 14985265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid.
    Chofflon M; Weiner HL; Morimoto C; Hafler DA
    Ann Neurol; 1989 May; 25(5):494-9. PubMed ID: 2528316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CD4+ and CD8+ T cells in demyelinating disease following Theiler's virus infection: a model for multiple sclerosis.
    Rodriguez M; Rivera-Quinones C; Murray PD; Kariuki Njenga M; Wettstein PJ; Mak T
    J Neurovirol; 1997 May; 3 Suppl 1():S43-5. PubMed ID: 9179791
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of CD8+ T cells in the pathogenesis of atopic asthma.
    Stanciu L
    Rom J Intern Med; 1994; 32(3):173-84. PubMed ID: 7866334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.